Phillip B. Hylemon

26.0k total citations · 8 hit papers
241 papers, 19.7k citations indexed

About

Phillip B. Hylemon is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Phillip B. Hylemon has authored 241 papers receiving a total of 19.7k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 95 papers in Oncology and 78 papers in Surgery. Recurrent topics in Phillip B. Hylemon's work include Drug Transport and Resistance Mechanisms (94 papers), Liver Disease Diagnosis and Treatment (62 papers) and Cholesterol and Lipid Metabolism (56 papers). Phillip B. Hylemon is often cited by papers focused on Drug Transport and Resistance Mechanisms (94 papers), Liver Disease Diagnosis and Treatment (62 papers) and Cholesterol and Lipid Metabolism (56 papers). Phillip B. Hylemon collaborates with scholars based in United States, China and Japan. Phillip B. Hylemon's co-authors include Jason M. Ridlon, Jasmohan S. Bajaj, Huiping Zhou, William M. Pandak, Douglas M. Heuman, Patrick M. Gillevet, Masoumeh Sikaroodi, Melanie B. White, Kalyani Daita and Emily C. Gurley and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Gastroenterology.

In The Last Decade

Phillip B. Hylemon

237 papers receiving 19.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bile salt biotransformations by human intestinal bacteria

2005 2.1k citations Jason M. Ridlon, Phillip B. Hylemon et al. Journal of Lipid Research profile →
Bile acids and the gut microbiome

2014 959 citations Jason M. Ridlon, Phillip B. Hylemon et al. profile →
Altered profile of human gut microbiome is associated with cirrhosis and its complications

2013 810 citations Jasmohan S. Bajaj, Douglas M. Heuman et al. profile →
Consequences of bile salt biotransformations by intestinal bacteria

2016 770 citations Jason M. Ridlon, Phillip B. Hylemon et al. profile →
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

2013 619 citations William M. Pandak, Patrick M. Gillevet et al. profile →
Bile acids as regulatory molecules

2009 562 citations Phillip B. Hylemon, Huiping Zhou et al. Journal of Lipid Research profile →
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

2012 414 citations Jasmohan S. Bajaj, Phillip B. Hylemon et al. profile →
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

2017 325 citations Prem Puri, Kalyani Daita et al. Hepatology profile →

Peers

Countries citing papers authored by Phillip B. Hylemon

Since Specialization

Citations

This map shows the geographic impact of Phillip B. Hylemon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip B. Hylemon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip B. Hylemon more than expected).

Fields of papers citing papers by Phillip B. Hylemon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip B. Hylemon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip B. Hylemon. The network helps show where Phillip B. Hylemon may publish in the future.

Co-authorship network of co-authors of Phillip B. Hylemon

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip B. Hylemon. A scholar is included among the top collaborators of Phillip B. Hylemon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip B. Hylemon. Phillip B. Hylemon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhalable tobramycin EEG powder formulation for treating Pseudomonas aeruginosa-induced lung infection 2024 ·International Journal of Pharmaceutics ·Rudra Pangeni, (unknown), Mohammad A. M. Momin, Dale Farkas, (unknown), Felicia Hall, Jason D. Kang, Phillip B. Hylemon, P. Worth Longest, Michael Hindle, Qingguo Xu	0
2	Long Noncoding RNA H19: A Novel Oncogene in Liver Cancer 2023 ·Non-Coding RNA ·Yanyan Wang, Jing Zeng, Weidong Chen, Jian‐Gao Fan, Phillip B. Hylemon, Huiping Zhou	18
3	Bile Acids and Biliary Fibrosis 2023 ·Cells ·Sayed Obaidullah Aseem, Phillip B. Hylemon, Huiping Zhou	9
4	RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression 2022 ·Cell & Bioscience ·Yanyan Wang, (unknown), (unknown), Jing Zeng, Derrick Zhao, Lianyong Su, (unknown), (unknown), Xuan Wang, Emily C. Gurley, Jinze Liu, Jinpeng Liu, Weidong Chen, Xiang‐Yang Wang, Arun J. Sanyal, Phillip B. Hylemon, Huiping Zhou	13
5	Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes 2020 ·PLoS ONE ·Yanyan Wang, Xiqiao Zhou, Derrick Zhao, Xuan Wang, Emily C. Gurley, Runping Liu, Xiaojiaoyang Li, Phillip B. Hylemon, Weidong Chen, Huiping Zhou	78
6	Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy 2019 ·The American Journal of Gastroenterology ·Jasmohan S. Bajaj, Andrew Fagan, Melanie B. White, James B. Wade, Phillip B. Hylemon, Douglas M. Heuman, Michael Fuchs, Binu V. John, Chathur Acharya, Masoumeh Sikaroodi, Patrick M. Gillevet	51
7	The role of sphingosine kinase 2 in alcoholic liver disease 2019 ·Digestive and Liver Disease ·(unknown), Runping Liu, Derrick Zhao, Xiaojiaoyang Li, Weiwei Zhu, Xuan Wang, Emily C. Gurley, Guan‐Hua Lai, Jimin Liu, Phillip B. Hylemon, Huiping Zhou	21
8	Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia 2019 ·Hepatology ·Yongtao Xiao, Runping Liu, Xiaojiaoyang Li, Emily C. Gurley, Phillip B. Hylemon, Ying Lu, Huiping Zhou, Wei Cai	107
9	Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant 2019 ·Hepatology ·Runping Liu, Jason D. Kang, R. Balfour Sartor, Masoumeh Sikaroodi, Andrew Fagan, Edith Gavis, Huiping Zhou, Phillip B. Hylemon, Jeremy Herzog, Xiaojiaoyang Li, (unknown), Javier González‐Maeso, James B. Wade, Siddhartha Ghosh, Emily C. Gurley, Patrick M. Gillevet, Jasmohan S. Bajaj	82
10	Cholangiocyte‐Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis 2019 ·Hepatology ·Runping Liu, Xiaojiaoyang Li, Weiwei Zhu, Yanyan Wang, Derrick Zhao, Xuan Wang, Emily C. Gurley, Guang Liang, Weidong Chen, Guan‐Hua Lai, William M. Pandak, H Lippman, Jasmohan S. Bajaj, Phillip B. Hylemon, Huiping Zhou	180
11	Cholangiocyte‐derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans 2018 ·Hepatology ·Xiaojiaoyang Li, Runping Liu, Zhiming Huang, Emily C. Gurley, Xuan Wang, Juan Wang, Hongliang He, Hu Yang, Guan‐Hua Lai, Luyong Zhang, Jasmohan S. Bajaj, Melanie B. White, William M. Pandak, Phillip B. Hylemon, Huiping Zhou	127
12	Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism 2017 ·Current Pharmacology Reports ·(unknown), Xiaojiaoyang Li, Phillip B. Hylemon, Huiping Zhou	26
13	C/EBP homologous protein–induced loss of intestinal epithelial stemness contributes to bile duct ligation–induced cholestatic liver injury in mice 2017 ·Hepatology ·Runping Liu, Xiaojiaoyang Li, Zhiming Huang, Derrick Zhao, (unknown), Guan‐Hua Lai, William M. Pandak, Phillip B. Hylemon, Jasmohan S. Bajaj, Arun J. Sanyal, Huiping Zhou	56
14	The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids breakdown → 2017 ·Hepatology ·Prem Puri, Kalyani Daita, Andrew Joyce, Faridoddin Mirshahi, Prasanna K. Santhekadur, Sophie C. Cazanave, Velimir A. Luketic, Mohammad Shadab Siddiqui, Sherry Boyett, Hae‐Ki Min, Divya P. Kumar, Rohit Kohli, Huiping Zhou, Phillip B. Hylemon, Melissa J. Contos, Michael O. Idowu, Arun J. Sanyal	325
15	A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine 2014 ·Molecular BioSystems ·Shenghua Gu, Bei Cao, Runbin Sun, (unknown), (unknown), Xiao‐Lei Wu, Linsheng Liu, Weibin Zha, Chunyan Zhao, Yan Li, (unknown), Phillip B. Hylemon, Huiping Zhou, Jiye Aa, Guangji Wang	69
16	Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens 2013 ·Journal of Lipid Research ·Jason M. Ridlon, Shigeo Ikegawa, João M. P. Alves, Biao Zhou, Akiko Kobayashi, Takashi Iida, Kuniko Mitamura, Genzoh Tanabe, Myrna G. Serrano, (unknown), (unknown), Gregory A. Buck, Phillip B. Hylemon	227
17	HIV Protease Inhibitors Disrupt Lipid Metabolism by Activating Endoplasmic Reticulum Stress and Inhibiting Autophagy Activity in Adipocytes 2013 ·PLoS ONE ·Beth Shoshana Zha, (unknown), Xiaoxuan Zhang, Weibin Zha, Jun Zhou, Martin Wabitsch, Guangji Wang, Vijay Lyall, Phillip B. Hylemon, Huiping Zhou	63
18	Prevention of free fatty acid–induced hepatic lipotoxicity by 18β-glycyrrhetinic acid through lysosomal and mitochondrial pathways 2008 ·Hepatology ·Xudong Wu, Luyong Zhang, Emily C. Gurley, Elaine Studer, Jing Shang, Tao Wang, Cuifen Wang, Ming Yan, Zhenzhou Jiang, Phillip B. Hylemon, Arun J. Sanyal, William M. Pandak, Huiping Zhou	139
19	Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. 2005 ·PubMed ·(unknown), Jason M. Ridlon, Phillip B. Hylemon	209
20	Regulation of bile acid synthesis 1991 ·Hepatology ·Reno Z. Vlahcevic, Douglas M. Heuman, Phillip B. Hylemon	171

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact